Structure Therapeutics, Inc. (GPCR)
21.88
-0.43
(-1.93%)
USD |
NASDAQ |
Oct 14, 16:00
21.80
-0.08
(-0.37%)
After-Hours: 05:16
Structure Therapeutics Total Long Term Debt (Quarterly) : 3.633M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.633M |
| March 31, 2026 | 3.183M |
| December 31, 2025 | 3.609M |
| September 30, 2025 | 4.288M |
| June 30, 2025 | 5.012M |
| March 31, 2025 | 5.116M |
| December 31, 2024 | 2.164M |
| September 30, 2024 | 2.673M |
| June 30, 2024 | 3.045M |
| Date | Value |
|---|---|
| March 31, 2024 | 3.525M |
| December 31, 2023 | 4.013M |
| September 30, 2023 | 3.034M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.272M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Eli Lilly & Co. | 49.62B |
| Novo Nordisk A/S | 18.63B |
| Pfizer Inc. | 63.10B |
| Viking Therapeutics, Inc. | 3.925M |
| Liquidia Corp. | 182.90M |